Ozempic
Weight is Weighing on the Majority of Americans, Survey Finds
A new report from Hims & Hers underscores the urgency of weight loss for Americans as companies race to distribute weight loss medications.
Consumers Unfazed by Cost of Weight Loss Meds, Yet Overpaying
GoodRx data shows that Americans overspent $200 million on weight loss medications like Ozempic and Wegovy.
Echelon Pushes into GLP-1 Space with ActiveMD
Echelon has been a fitness industry player since 2017—and now it’s leveling up with ActiveMD, offering customers access to weight loss drugs.
Noom Adds Body Scan Tech for GLP-1 Users
Noom has partnered with Prism Labs to give GLP-1 users a way to monitor and track body composition and muscle mass.
WeightWatchers CEO Exits
Sima Sistani is out as CEO of WeightWatchers after leading the weight loss company for two years. Tara Comonte will serve as interim CEO.
The 8 Trends Driving the Supplements Market
Here’s the trends XRC, a venture capital firm, says will continue fueling the vitamins, minerals and supplement space
SoWell Launches Product that Bio-Hacks Against GLP-1 Side Effects
GLP-1 Drugs Like Ozempic will now be more tolerable thanks to metabolic health brand SoWell’s latest launch
FuturHealth Launches Custom Meal Plans, Integrating Nutrition with GLP-1s
The weight-loss solutions company is filling the gap between medications and nutrition with its Custom Meal Plans
Can Fitness Programs Help Ozempic Users Keep Their Muscle?
A new market has emerged which focuses on maintaining the lean muscle mass of consumers taking weight-loss drugs like Ozempic.
Equinox Designs Training Program for Members on Weight Loss Drugs
Luxury fitness brand Equinox is creating a program designed to help Ozempic and Wegovy users build long-term, healthy habits.
